All filters
Videos
Long-Acting Therapy for PrEP: How Will We Use it?- Mr. Luis Mendão
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2021
Videos
Update on Guidelines for Preventing MTCT of Hep B- Dr. Philippa Easterbrook
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2021
Videos
Update on the Use of Generic Drugs for HIV in Europe- Ms. Liudmyla Maistat
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2021
Videos
Implementation of Integrase Inhibitors for First Line Therapy in the CEE Region: How Far Are We?- Prof. Milosz Parczewski
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2021
Videos
EASL Guidelines on Viral Hepatitis Elimination- Prof. Mojca Matičič
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2021
Videos
The Georgian Model for Hepatitis C Elimination (With Reflection on the Impact of COVID-19 Pandemic)- Prof. Nicole Seguy
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2021
E-Posters
“Evaluate potential impact of COVID-19 pandemic on HIV testing and care national program in the republic of Georgia”
O. Chokoshvili
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2021
E-Posters
Effect of remdesivir on mortality in patients with COVID-19: A retrospective cohort study
R. Metchurtchlishvili
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2021
E-Posters
Integrating viral hepatitis and PrEP services through KP-led clinics in Vietnam: An opportunity to achieve dual elimination of HIV and viral hepatitis by 2030
B. Vu
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2021
E-Posters
Prevalence of undiagnosed HBV infection in patients with COVID-19
O. Sandulescu
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2021
E-Posters
Post-discharge mortality among hospitalized HIV positive persons
N. Rukhadze
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2021
E-Posters
Surveillance of SARS-CoV-2 among employees of front-line healthcare facility in Tbilisi Georgia
N. Chkhartishvili
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2021
E-Posters
Outcomes of HIV pre-exposure prophylaxis (PrEP) program in Georgia for the reporting period from October 2017 to June 2021
E. Karkashadze
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2021
E-Posters
Prevalence of hyperglycemia and its impact on mortality among HIV patients in Georgia
T. Nozadze
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2021
E-Posters
Incidence and residual risk of HCV in Lithuanian blood donors from 2004 to 2018: call for screening improvement in a general population
S. Grubyte
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2021
E-Posters
Assessment of HCV screening and linkage to care modalities within the Georgia’s national hepatitis C elimination program and designing the most optimal models for reaching the elimination targets
A. Abutidze
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2021
E-Posters
Surveillance of recent HIV infection in Georgia, 2018-2020
M. Karchava
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2021
E-Posters
Molecular epidemiology of hepatitis C virus isolated from patients with newly diagnosed HCV infection in 2017-2021
N. Matsiyeuskaya
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2021
E-Posters
“ALT flare” implication into further TDF-containing chronic hepatitis B therapy effectiveness among people living with HIV
T. Melnyk
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2021
E-Posters
A series of cases of HIV and acute hepatitis B coinfection – treatment issues
M. Irimia
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2021
E-Posters
Progress in roll-out of generic dolutegravir-based treatment in Georgia
N. Chkhartishvili
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2021
E-Posters
Latvia on its’ way to achieve WHO plan to eliminate hepatitis C by 2030.
E. Liepina
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2021
E-Posters
Hepatitis C virus treatment response to sofosbuvir/ledipasvir among adolescents coinfected with HIV and HCV: Real world data from Ukraine
F. Malik
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2021
E-Posters
Co-infections with hepatitis virus B and C among patients with human immunodeficiency virus in a regional center of HIV/AIDS from northeastern Romania
C. Sapaniuc
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2021